Drugs / Ancrod
Ancrod
also known as
Viprinex · Acc-c · Arvin · Arwin · Ec 3.4.21.74 · Protein c activator · Proteinase, agkistrodon serine · Venombin-a
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01621256 | May 2013 → Sep 2018 | sensorineural hearing loss disorder | Nordmark Arzneimittel GmbH & Co. KG | Completed | No outcome recorded |
| Phase 33 trials · 1 missed | ||||||
| Phase 3 | NCT00300196 | Mar 2006 → Dec 2008 | brain infarction, brain ischemia, stroke disorder | Neurobiological Technologies | Terminated | No outcome recorded |
| Phase 3 | NCT00141011 | Sep 2005 → Dec 2008 | brain infarction, brain ischemia, stroke disorder | Neurobiological Technologies | Terminated | No outcome recorded |
| Phase 3 | NCT00343174 | — | brain infarction, brain ischemia, stroke disorder | Heidelberg University | Completed | Missed primary |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ancrod | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01621256 ↗ |
| Known as | Acc-c | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108481 ↗ |
| Known as | Arvin | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108481 ↗ |
| Known as | Arwin | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108481 ↗ |
| Known as | Ec 3.4.21.74 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108481 ↗ |
| Known as | Protein c activator | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108481 ↗ |
| Known as | Proteinase, agkistrodon serine | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108481 ↗ |
| Known as | Venombin-a | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108481 ↗ |
| Known as | Viprinex | “Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke” NCT00141011 ↗1“Biological: Ancrod (Viprinex)” NCT00300196 ↗ |
| Route | Intravenous | “Intravenous ancrod” NCT00141011 ↗ |